American Herbal Products Association (AHPA)
U.S. Supreme Court Rules Trump’s Tariffs Unlawful, Questions Remain
On Feb. 20, the United States Supreme Court ruled in the consolidated case Learning Resources, Inc. v. Trump that the International Emergency Economic Powers Act (IEEPA) does not grant the President of the United States the authority to impose tariffs. The ruling found almost all the major tariffs implemented by the current administration were unlawful, including wide-ranging, nation-scale ...
AHPA Rebuts Washington Post Article Based on Retracted Study
The American Herbal Products Association (AHPA) issued a statement regarding a Feb. 2 article published in The Washington Post titled “Can Supplements Reduce Cancer Risk?” AHPA said the author referenced an investigation targeting herbal supplements that was built on a retracted study and repeatedly asserts the dietary supplement industry is “not well regulated.” In response, ...
Expo West Celebrates 45 Years, Plans Biggest Show to Date
Natural Products Expo West returns to the Anaheim Convention Center in Anaheim, CA from March 3-6. According to show organizers, 2026 is a milestone year as Expo West celebrates 45 years with the biggest show to date. The new CPG Innovation Summit is a one-day immersive experience built to connect brands with the resources they ...
U.S. Representative Introduces Dietary Supplement Regulatory Uniformity Act
On Feb. 4, U.S. Representative Nick Langworthy (R-NY) introduced the Dietary Supplement Regulatory Uniformity Act, legislation aimed at protecting consumer health while restoring common sense to dietary supplement regulation by reaffirming a single, science-based national standard overseen by the U.S. Food and Drug Administration (FDA). According to Langworthy, dietary supplements including vitamins, protein powders, creatine ...
Dick Durbin Reintroduces Dietary Supplement Listing Act
On Jan. 15, U.S. Senator Dick Durbin (D-IL) reintroduced the Dietary Supplement Listing Act, which would require dietary supplement manufacturers to register their products with the U.S. Food and Drug Administration (FDA). According to Durbin, the law would require companies to provide FDA with critical information about their products including product names, a list of ...
FDA Issues Letter on DSHEA Disclaimer Amendment, Industry Responds
On Dec. 11, the U.S. Food and Drug Administration (FDA) published a letter to the dietary supplement industry regarding the agency’s labeling regulations that govern the placement of the disclaimer on dietary supplements labels under the Federal Food, Drug, and Cosmetic Act (FD&C) and Dietary Supplement Health and Education Act of 1994 (DSHEA). The agency ...
Administration Provides Tariff Relief for Certain Botanical Ingredients
As part of an executive order issued on Nov. 14, President Donald Trump revised and expanded the set of commodities in the Harmonized Tariff Schedule (HTS) that are exempt from reciprocal tariffs. These changes, which are reflected in updates to Annex II and Annex III partially target commodities that cannot be sourced within the United ...
AHPA Responds to Annex III Tariff Rules for Herbal Commodities
On Sept. 5, President Donald Trump passed a new executive order taking a range of actions regarding the tariff policies. The changes include the addition of Annex III, which contains commodities that may be exempt from the reciprocal tariffs. According to the American Herbal Products Association (AHPA), the herbal commodities in Annex III include those ...
Trade Associations Send Joint Letter Regarding FSA/HSA Proposals
The American Herbal Products Association (AHPA), the Council for Responsible Nutrition (CRN), the Consumer Healthcare Products Association (CHPA) and the United Natural Products Alliance (UNPA) sent a joint letter to the Internal Revenue Service (IRS) to obtain coverage for dietary supplements under Flexible Spending Accounts (FSAs) and Healthcare Savings Accounts (HSAs). There is also a ...
FDA Takes Steps to Restrict 7-OH Opioid Products
On July 29, the U.S. Food and Drug Administration (FDA) took “bold steps” to protect American consumers from dangerous illegal opioids. The agency recommended a scheduling action to control certain 7-hydroxymitragyine (7-OH) products under the Controlled Substances Act. According to FDA, 7-OH is increasingly recognized for numerous health and safety issues because of its ability ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Vitamin Retailer magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listing:
Subscribe To Our Newsletter
Stay Informed! Breaking news, industry trends featured topics, and more.
Subscribe to our newsletter today!